Imunon, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Imunon, Inc. (IMNN) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 2.65 thousand shares as of 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-03-31
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2.65K shares; Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed 39.70K shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2.14K shares; Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed 32.10K shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 69.65K shares.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 1.48K shares; Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed 1.58K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2024-12-31 | 2.65K shares 10-K · filed 2026-03-31 | 39.70K shares 10-K · filed 2025-02-27 |
| 2023-12-31 | 2.14K shares 10-K · filed 2026-03-31 | 32.10K shares 10-K · filed 2024-03-28 |
| 2022-12-31 | 69.65K shares 10-K · filed 2025-02-27 | |
| 2021-12-31 | 1.48K shares 10-K · filed 2024-03-28 | 1.58K shares 10-K · filed 2022-03-31 |
| 2020-12-31 | 83.00 shares 10-K · filed 2023-03-30 | 2.75K shares 10-K · filed 2021-03-19 |
| 2019-12-31 | 583.00 shares 10-K · filed 2022-03-31 | 8.75K shares 10-K · filed 2021-03-19 |
| 2019-03-31 | 1.79M shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 22.50K shares 10-K · filed 2021-03-19 | 1.59M shares 10-Q · filed 2019-05-15 |
| 2016-12-31 | 67.00K shares 10-K · filed 2017-03-24 | |
| 2015-12-31 | 81.52K shares 10-K · filed 2017-03-24 | |
| 2014-12-31 | 7.02K shares 10-K · filed 2017-03-24 | |
| 2014-06-30 | 15.27K shares 10-Q · filed 2014-08-07 | |
| 2014-03-31 | 521.00 shares 10-Q · filed 2014-05-08 | |
| 2013-12-31 | 2.11K shares 10-K · filed 2016-03-30 | 1.56K shares 10-K · filed 2014-03-13 |
| 2013-09-30 | 3.04K shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 13.67K shares 10-Q · filed 2013-08-08 | |
| 2013-03-31 | 19.34K shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 4.30K shares 10-K · filed 2016-03-30 | 19.33K shares 10-K · filed 2013-03-18 |
| 2012-09-30 | 44.17K shares 10-Q · filed 2012-11-09 | |
| 2012-06-30 | 53.17K shares 10-Q · filed 2012-08-14 | |
| 2011-12-31 | 12.19K shares 10-K · filed 2015-03-12 | 54.87K shares 10-Q · filed 2012-08-14 |
| 2010-12-31 | 17.20K shares 10-K · filed 2014-03-13 | 77.40K shares 10-K · filed 2013-03-18 |
| 2009-12-31 | 78.60K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |